RESUMO

Different diagnostic considerations take place when a diarrhea of recent development and prolonged or atypical course is evaluated. Infectious colitis, including Clostridium difficile colitis, and inflammatory bowel disease are the main diagnosis that we put into consideration. We present a 42-year-old woman that begins with diarrhea of probable infectious cause. Because of the recurrence of the symptoms we arrived to the diagnosis of Clostridium difficile colitis complicating an ulcerative colitis. Clostridium difficile colitis has particular characteristic in the context of an inflammatory bowel disease. We should know them because appropriate treatment improves the prognosis.

Assuntos

RESUMO

Oesophageal candidiasis is an epithelial infection which requires an immune deficiency. C. albicans is commonly the cause, although other species may also be responsible. Resistance to fluconazole, drug of choice for treatment, is an emerging problem. The objectives of the current paper were: to determine the frequency of oesophageal candidiasis in patients submitted to upper gastrointestinal endoscopy, analyze risk factors, identify Candida species and determine in vitro susceptibility to fluconazole. During 12 months, 34 patients with oesophageal candidiasis were detected. Out of 1.230 HIV negative and 91 HIV positive patients submitted to upper endoscopy, 11 (0.9%) and 23 (25.3%), respectively, had candidiasis. Risk factors for HIV negative patients were systemic antibiotic therapy in 2, deficient dental cleaning in 2 aged patients, use of proton pump inhibitors in 3, inhaled steroids in 2, malignancy in 1 and oral steroids in 1. The histopathologic diagnosis was confirmed in 48.6% of cases. Cultures were positive in 91.2% C. albicans was prevalent (93.5%), and was associated to other species in 5 cases (16.1%), (3 C. glabrata, 1 C. tropicalis and 1 C. parapsilosis). One case cultured only C. glabrata and 1, only C tropicalis. Out of 31 cultures, 25 were susceptible to fluconazole, 4 dose dependent (1 C. albicans, 3 C. glabrata), and 2 resistant (1 C. albicans, 1 C. glabrata). Frequency of oesophageal candidiasis was low, except for HIV positive patients. The most common etiologic agent was C. albicans, though other Candida species were also found. C. albicans and C. glabrata showed dose dependency and resistance to fluconazole.

Assuntos

RESUMO

Oesophageal candidiasis is an epithelial infection which requires an immune deficiency. C. albicans is commonly the cause, although other species may also be responsible. Resistance to fluconazole, drug of choice for treatment, is an emerging problem. The objectives of the current paper were: to determine the frequency of oesophageal candidiasis in patients submitted to upper gastrointestinal endoscopy, analyze risk factors, identify Candida species and determine in vitro susceptibility to fluconazole. During 12 months, 34 patients with oesophageal candidiasis were detected. Out of 1.230 HIV negative and 91 HIV positive patients submitted to upper endoscopy, 11 (0.9

) and 23 (25.3

), respectively, had candidiasis. Risk factors for HIV negative patients were systemic antibiotic therapy in 2, deficient dental cleaning in 2 aged patients, use of proton pump inhibitors in 3, inhaled steroids in 2, malignancy in 1 and oral steroids in 1. The histopathologic diagnosis was confirmed in 48.6

of cases. Cultures were positive in 91.2

C. albicans was prevalent (93.5

), and was associated to other species in 5 cases (16.1

), (3 C. glabrata, 1 C. tropicalis and 1 C. parapsilosis). One case cultured only C. glabrata and 1, only C tropicalis. Out of 31 cultures, 25 were susceptible to fluconazole, 4 dose dependent (1 C. albicans, 3 C. glabrata), and 2 resistant (1 C. albicans, 1 C. glabrata). Frequency of oesophageal candidiasis was low, except for HIV positive patients. The most common etiologic agent was C. albicans, though other Candida species were also found. C. albicans and C. glabrata showed dose dependency and resistance to fluconazole.

RESUMO

UNLABELLED: Upper gastrointestinal symptoms such as nausea, vomiting, upper abdominal pain, heartburn, early satiety, bloating and anorexia, are frequently reported by HIV positive patients; however, their prevalence and diagnostic approach are unknown. AIMS: To evaluate the frequency of endoscopic and histologic diagnosis in HIV positive patients with upper gastrointestinal symptoms referred to upper endoscopy, and to compare them with those found in a non-HIV infected group with similar symptoms. PATIENTS AND METHODS: Out of 132 HIV positive patients referred to upper endoscopy, 102 (75%) with upper gastrointestinal symptoms, and 177 non-HIV controls were prospectively included. All patients answered questionnaires assessing frequency, severity and impact of symptoms on quality of life, and underwent upper endoscopy with systematic mucosal biopsies from esophagus, stomach and distal duodenum. RESULTS: Upper abdominal pain, heartburn and bloating were the most common upper gastrointestinal symptom reported in both groups. Anorexia, nausea, vomiting and early satiety were more frequent among HIV positive patients (p = or < 0.01). Intensity and impact of symptoms quality of life were higher in this group (p = 0.0001). Opportunistic infections were detected in 29 (28.4%) HIV positive patients. This subgroup had a lower mean CD4 count (p = 0.0004). In 76 (75.4%) HIV positive non-opportunistic diseases were diagnosed, with similar frequency to HIV negative individuals. CONCLUSIONS: Upper endoscopy with biopsies detected opportunistic and non-opportunistic diseases in HIV positive patients with upper gastrointestinal symptoms. Opportunistic diseases were related to lower CD4 counts. Non-opportunistic diseases had similar frequency in both groups, HIV positive and negative controls.

Assuntos

RESUMO

AIM: To determine prospectively the long-term evolution of patients with neurological diseases after insertion of percutaneous endoscopic gastrostomy (PEG). METHODS: 109 PEG were performed in 99 consecutive patients (49 females, 50 males), mean age 75 years (range: 20-97 years) as an alternative to a nasogastric tube. Patients were enterally fed because of chronic neurological swallowing difficulties: cerebrovascular disease 38, dementia 27, disordered swallowing mechanisms in elderly patients 10, motor neurona disease and multiple sclerosis 10, neuro-surgical disease 6, Parkinson's disease 3, brain tumor 3, neo-natal encephalopathy 1, HIV encephalopathy 1. The procedure took place in a dedicated endoscopy room. In all cases, prophylatic antibiotics were given and the PEG tube was inserted by the "pull" technique. RESULTS: PEG insertion was technically succesful in all cases. After PEG insertion, all patients were subsequently discharged to local nursing home facilities. 85/99 patients were long-term followed-up on an outpatient basis, 25% of them were followed for more than a year. The mean follow-up time was 3 months (range: 1-24 months). The most frequent complication were minor: local wound infection 6, ostomy leakage 8, silicon degradation 16, leading to the removal of the PEG and the placement of a new PEG tubes in 10 cases. Two major complications were observed : one gastric perforation and death 2 months after the PEG placement and one gastrocolic fistula. No aspiration pneumonia was reported. In one patient, PEG was removed after recuperation of a normal swallowing. All patients had a nutritional improvement. A total of 11 deaths occurred during the follow-up, related to the neurological disorder in 10/11 cases. Nursing home team, patient's physicians and patient's families found PEG manipulations easier than naso-gastric tube. CONCLUSION: Our study suggests that PEG is a method of choice for enteral feeding of patients with chronic neurological disorders. PEG is well-tolerated, leading to an improvement in nutritional status and offering good facilities for home nursing.

Assuntos

RESUMO

Upper gastrointestinal symptoms such as nausea, vomiting, upper abdominal pain, heartburn, early satiety, bloating and anorexia, are frequently reported by HIV positive patients; however, their prevalence and diagnostic approach are unknown. AIMS: To evaluate the frequency of endoscopic and histologic diagnosis in HIV positive patients with upper gastrointestinal symptoms referred to upper endoscopy, and to compare them with those found in a non-HIV infected group with similar symptoms. PATIENTS AND METHODS: Out of 132 HIV positive patients referred to upper endoscopy, 102 (75

) with upper gastrointestinal symptoms, and 177 non-HIV controls were prospectively included. All patients answered questionnaires assessing frequency, severity and impact of symptoms on quality of life, and underwent upper endoscopy with systematic mucosal biopsies from esophagus, stomach and distal duodenum. RESULTS: Upper abdominal pain, heartburn and bloating were the most common upper gastrointestinal symptom reported in both groups. Anorexia, nausea, vomiting and early satiety were more frequent among HIV positive patients (p = or < 0.01). Intensity and impact of symptoms quality of life were higher in this group (p = 0.0001). Opportunistic infections were detected in 29 (28.4

) HIV positive patients. This subgroup had a lower mean CD4 count (p = 0.0004). In 76 (75.4

) HIV positive non-opportunistic diseases were diagnosed, with similar frequency to HIV negative individuals. CONCLUSIONS: Upper endoscopy with biopsies detected opportunistic and non-opportunistic diseases in HIV positive patients with upper gastrointestinal symptoms. Opportunistic diseases were related to lower CD4 counts. Non-opportunistic diseases had similar frequency in both groups, HIV positive and negative controls.

RESUMO

AIM: To determine prospectively the long-term evolution of patients with neurological diseases after insertion of percutaneous endoscopic gastrostomy (PEG). METHODS: 109 PEG were performed in 99 consecutive patients (49 females, 50 males), mean age 75 years (range: 20-97 years) as an alternative to a nasogastric tube. Patients were enterally fed because of chronic neurological swallowing difficulties: cerebrovascular disease 38, dementia 27, disordered swallowing mechanisms in elderly patients 10, motor neurona disease and multiple sclerosis 10, neuro-surgical disease 6, Parkinsons disease 3, brain tumor 3, neo-natal encephalopathy 1, HIV encephalopathy 1. The procedure took place in a dedicated endoscopy room. In all cases, prophylatic antibiotics were given and the PEG tube was inserted by the [quot ]pull[quot ] technique. RESULTS: PEG insertion was technically succesful in all cases. After PEG insertion, all patients were subsequently discharged to local nursing home facilities. 85/99 patients were long-term followed-up on an outpatient basis, 25

of them were followed for more than a year. The mean follow-up time was 3 months (range: 1-24 months). The most frequent complication were minor: local wound infection 6, ostomy leakage 8, silicon degradation 16, leading to the removal of the PEG and the placement of a new PEG tubes in 10 cases. Two major complications were observed : one gastric perforation and death 2 months after the PEG placement and one gastrocolic fistula. No aspiration pneumonia was reported. In one patient, PEG was removed after recuperation of a normal swallowing. All patients had a nutritional improvement. A total of 11 deaths occurred during the follow-up, related to the neurological disorder in 10/11 cases. Nursing home team, patients physicians and patients families found PEG manipulations easier than naso-gastric tube. CONCLUSION: Our study suggests that PEG is a method of choice for enteral feeding of patients with chronic neurological disorders. PEG is well-tolerated, leading to an improvement in nutritional status and offering good facilities for home nursing.

RESUMO

Opportunistic esophageal infections (Candida, cytomegalovirus, herpes simplex virus) and idiophatic esophageal ulcerations are commonly found in HIV patients. However, motility disorders of the esophagus have seldom been investigated in this population. The aim of this prospective study was to determine the presence of motility disorders in HIV patients with esophageal symptoms (with or without associated lesions detected by endoscopy) and in HIV patients without esophageal symptoms and normal esophagoscopy. Eigthteen consecutive HIV patients (10 male, 8 female, ages 20-44 years, mean age 33.5; 8 HIV positive and 10 AIDS) were studied prospectively. Nine patients complained of esophageal symptoms, e.g, dysphagia/odynophagia (group 1) and 9 had symptoms not related to esophageal disease, such as diarrhea, abdominal pain, or gastrointestinal bleeding (group 2). All patients underwent upper endoscopy; mucosal biopsies were taken when macroscopic esophageal lesions were identified or when the patients were symptomatic even if the esophageal mucosa was normal. Esophageal manometry was performed in the 18 patients, using a 4-channel water-perfused system according to a standardized technique. Sixteen of the 18 patients (88.8%) had baseline manometric abnormalities. In group 1, 8/9 patients had esophageal motility disorders: nutcrackeresophagus in 1, hypertensive lower esophageal sphincter (LES) with incomplete relaxation in 2, nonspecific esophageal motility disorders (NEMD) in 3, diffuse esophageal spasm in 1, esophageal hypocontraction with low LES pressure in 1. Six of these 9 patients had lesions detected by endoscopy: CMV ulcers in 2, idiopathic ulcers in 1, candidiasis in 1, idiopathic ulcer + candidiasis in 1, nonspecific esophagitis in 1; and 3/9 had normal endoscopy and normal esophageal biopsies. In group 2, 8/9 patients had abnormal motility: hypertensive LES with incomplete relaxation in 1, nutcracker esophagus in 2, esophageal hypocontraction in 3, and NEMD in 2. All these patients had a normal esophageal mucosa at endoscopy. In conclusion, our findings suggest that HIV patients have esophageal motility disorders independent of esophageal symptoms and/or the presence of mucosal esophageal lesions.

Assuntos